Affiliated publications

Acknowledging ERN RARE-LIVER in a publication adds to the prominence of the network and provides a chance for fruitful collaboration. Affiliated Scientific Publications involve as major contributors at least two Health Care Providers from two different Member States within the ERN and acknowledge the ERN.

Affiliated Scientific Publications

2021

  • Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding. Walter A, Rudler M, Olivas P, Moga L, Trépo E, Robic MA, Ollivier-Hourmand I, Baiges A, Sutter O, Bouzbib C, Peron JM, Le Pennec V, Ganne-Carrié N, Garcia-Pagán JC, Mallet M, Larrue H, Dao T, Thabut D, Hernández-Gea V, Nault JC, Bureau C, Allaire M; Salvage TIPS Group. Hepatology. 2021 May 21. doi: 10.1002/hep.31913.
  • Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease. Bassegoda O, Olivas P, Turco L, Mandorfer M, Serra-Burriel M, Tellez L, Kwanten W, Laroyenne A, Farcau O, Alvarado E, Moga L, Vuille-Lessard E, Fortea JI, Ibañez L, Tosetti G, Vanwolleghem T, Larrue H, Burgos-Santamaría D, Stefanescu H, Paternostro R, Cippitelli A, Lens S, Augustin S, Llop E, Laleman W, Trebicka J, Chang J, Masnou H, Zipprich A, Miceli F, Semmler G, Forns X, Primignani M, Bañares R, Puente A, Berzigotti A, Rautou PE, Villanueva C, Ginès P, Garcia-Pagan JC, Procopet B, Bureau C, Albillos A, Francque S, Reiberger T, Schepis F, Graupera I, Hernandez-Gea V. Clin Gastroenterol Hepatol. 2021 Oct 21:S1542-3565(21)01136-8. doi: 10.1016/j.cgh.2021.10.023.
  • Defining Primary Sclerosing Cholangitis: Results from an International PSC Study Group consensus process. Ponsioen CY, Assis DN, Boberg KM, Bowlus CL, Deneau M, Thorburn D, Aabakken L, Färkkilä M, Petersen B, Rupp C, Hübscher SG; IPSCSG. Gastroenterology. 2021 Aug 9:S0016-5085(21)03346-1. doi: 10.1053/j.gastro.2021.07.046.
  • Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease. Lackner C, Stauber RE, Davies S, Denk H, Dienes HP, Gnemmi V, Guido M, Miquel R, Paradis V, Schirmacher P, Terracciano L, Berghold A, Pregartner G, Binder L, Douschan P, Rainer F, Sygulla S, Jager M, Rautou PE, Bumbu A, Horhat A, Rusu I, Stefanescu H, Detlefsen S, Krag A, Thiele M, Cortez-Pinto H, Moreno C, Gouw ASH, Tiniakos DG. J Hepatol. 2021 Oct;75(4):810-819. doi: 10.1016/j.jhep.2021.05.029.
  • Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data. Nicoară-Farcău O, Han G, Rudler M, Angrisani D, Monescillo A, Torres F, Casanovas G, Bosch J, Lv Y, Thabut D, Fan D, Hernández-Gea V, García-Pagán JC; Preemptive TIPS Individual Data Metanalysis, International Variceal Bleeding Study and Baveno Cooperation Study groups. Gastroenterology. 2021 Jan;160(1):193-205.e10. doi: 10.1053/j.gastro.2020.09.026.
  • Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study. Baumann U, Sturm E, Lacaille F, Gonzalès E, Arnell H, Fischler B, Jørgensen MH, Thompson RJ, Mattsson JP, Ekelund M, Lindström E, Gillberg PG, Torfgård K, Soni PN. Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101751. doi: 10.1016/j.clinre.2021.101751.
  • Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study. Gonzales E, Hardikar W, Stormon M, Baker A, Hierro L, Gliwicz D, Lacaille F, Lachaux A, Sturm E, Setchell KDR, Kennedy C, Dorenbaum A, Steinmetz J, Desai NK, Wardle AJ, Garner W, Vig P, Jaecklin T, Sokal EM, Jacquemin E. Lancet. 2021 Oct 30;398(10311):1581-1592. doi: 10.1016/S0140-6736(21)01256-3.
  • Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021. Spaander MCW, van der Bogt RD, Baron TH, Albers D, Blero D, de Ceglie A, Conio M, Czakó L, Everett S, Garcia-Pagán JC, Ginès A, Jovani M, Repici A, Rodrigues-Pinto E, Siersema PD, Fuccio L, van Hooft JE. Endoscopy. 2021 Jul;53(7):751-762. doi: 10.1055/a-1475-0063.
  • Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review. Engel B, Laschtowitz A, Janik MK, Junge N, Baumann U, Milkiewicz P, Taubert R, Sebode M. Eur J Med Genet. 2021 Jun;64(6):104214. doi: 10.1016/j.ejmg.2021.104214.
  • Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency. Fromme M, Schneider CV, Pereira V, Hamesch K, Pons M, Reichert MC, Benini F, Ellis P, H Thorhauge K, Mandorfer M, Burbaum B, Woditsch V, Chorostowska-Wynimko J, Verbeek J, Nevens F, Genesca J, Miravitlles M, Nuñez A, Schaefer B, Zoller H, Janciauskiene S, Abreu N, Jasmins L, Gaspar R, Liberal R, Macedo G, Mahadeva R, Gomes C, Schneider KM, Trauner M, Krag A, Gooptu B, Thorburn D, Marshall A, Hurst JR, Lomas DA, Lammert F, Gaisa NT, Clark V, Griffiths W, Trautwein C, Turner AM, McElvaney NG, Strnad P. Gut. 2021 Feb 25:gutjnl-2020-323729. doi: 10.1136/gutjnl-2020-323729.
  • Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. Laschtowitz A, Zachou K, Lygoura V, Pape S, Derben F, Jaeckel E, Oller-Moreno S, Weidemann S, Krech T, Piecha F, Schön G, Liebhoff AM, Al Tarrah M, Heneghan M, Drenth JPH, Dalekos G, Taubert R, Lohse AW, Schramm C. JHEP Rep. 2021 Jun 12;3(4):100321. doi: 10.1016/j.jhepr.2021.100321.
  • Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. Arab JP, Díaz LA, Baeza N, Idalsoaga F, Fuentes-López E, Arnold J, Ramírez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W, Clark V, Simonetto D, Ahn JC, Buryska S, Mehta TI, Stefanescu H, Horhat A, Bumbu A, Dunn W, Attar B, Agrawal R, Haque ZS, Majeed M, Cabezas J, García-Carrera I, Parker R, Cuyàs B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de la Tijera MF, Kulkarni AV, Rao PN, Guerra Salazar P, Skladaný L, Bystrianska N, Prado V, Clemente-Sanchez A, Rincón D, Haider T, Chacko KR, Cairo F, de Sousa Coelho M, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Narvaez A, Bessone F, Marcelo JS, Piombino D, Dirchwolf M, Arancibia JP, Altamirano J, Kim W, Araujo RC, Duarte-Rojo A, Vargas V, Rautou PE, Issoufaly T, Zamarripa F, Torre A, Lucey MR, Mathurin P, Louvet A, García-Tsao G, González JA, Verna E, Brown RS, Roblero JP, Abraldes JG, Arrese M, Shah VH, Kamath PS, Singal AK, Bataller R. J Hepatol. 2021 Nov;75(5):1026-1033. doi: 10.1016/j.jhep.2021.06.019.
  • Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency. van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Shneider BL, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Algoufi T, Mazhar N, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler B, Hulscher JBF, Serranti D, Arikan C, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Luigi Calvo P, Krebs-Schmitt D, Hartleif S, van der Woerd WL, Wang JS, Li LT, Durmaz Ö, Kerkar N, Hørby Jørgensen M, Fischer R, Jimenez-Rivera C, Alam S, Cananzi M, Laverdure N, Ferreira CT, Ordonez F, Wang H, Sency V, Kim KM, Chen HL, Carvalho E, Fabre A, Quintero Bernabeu J, Alonso EM, Sokol RJ, Suchy FJ, Loomes KM, McKiernan PJ, Rosenthal P, Turmelle Y, Rao GS, Horslen S, Kamath BM, Rogalidou M, Karnsakul WW, Hansen B, Verkade HJ. Hepatology. 2021 Mar 5. doi: 10.1002/hep.31787.
  • Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases. Baiges A, Cerda E, Amicone C, Téllez L, Alvarado-Tapias E, Puente A, Fortea JI, Llop E, Rocha F, Orts L, Ros-Fargas O, Vizcarra P, Zekrini K, Lounes OA, Touati G, Jiménez-Esquivel N, Serrano MJ, Falgà A, Magaz M, Olivas P, Betancourt F, Perez-Campuzano V, Turon F, Payancé A, Goria O, Rautou PE, Hernández-Gea V, Villanueva C, Albillos A, Plessier A, García-Pagán JC. Clin Gastroenterol Hepatol. 2021 Dec 27:S1542-3565(21)01356-2. doi: 10.1016/j.cgh.2021.12.032.
  • Intravenous ketamine and progressive cholangiopathy in COVID-19 patients. Keta-Cov research group. Electronic address: vincent.mallet@aphp.fr; Keta-Cov research group. J Hepatol. 2021 May;74(5):1243-1244. doi: 10.1016/j.jhep.2021.02.007.
  • Management of the major complications of cirrhosis: Beyond guidelines. Garcia-Pagan JC, Francoz C, Montagnese S, Senzolo M, Mookerjee RP. J Hepatol. 2021 Jul;75 Suppl 1:S135-S146. doi: 10.1016/j.jhep.2021.01.027.
  • MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis. Janik MK, Smyk W, Kruk B, Szczepankiewicz B, Górnicka B, Lebiedzińska-Arciszewska M, Potes Y, Simões ICM, Weber SN, Lammert F, Więckowski MR, Milkiewicz P, Krawczyk M. Sci Rep. 2021 Dec 23;11(1):24407. doi: 10.1038/s41598-021-03521-3.
  • Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis. Janik MK, Kruk B, Szczepankiewicz B, Kostrzewa K, Raszeja-Wyszomirska J, Górnicka B, Lammert F, Milkiewicz P, Krawczyk M. Liver Int. 2021 Feb;41(2):348-356. doi: 10.1111/liv.14726.
  • Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship. Karkucinska-Wieckowska A, Simoes ICM, Kalinowski P, Lebiedzinska-Arciszewska M, Zieniewicz K, Milkiewicz P, Górska-Ponikowska M, Pinton P, Malik AN, Krawczyk M, Oliveira PJ, Wieckowski MR. Eur J Clin Invest. 2021 May 29:e13622. doi: 10.1111/eci.13622.
  • Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study. Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, Rıza Calışkan A, Peralta M, Gerussi A, Massoumi H, Catana AM, Torgutalp M, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Kacmaz H, Nazal L, Frager S, Demir N, Irak K, Ellik ZM, Balaban Y, Atay K, Eren F, Cristoferi L, Batıbay E, Urzua Á, Snijders R, Kıyıcı M, Akyıldız M, Ekin N, Carr RM, Harputluoğlu M, Hatemi I, Mendizabal M, Silva M, Idilman R, Silveira M, Drenth JPH, Assis DN, Björnsson E, Boyer JL, Invernizzi P, Levy C, Schiano TD, Ridruejo E, Wahlin S. Hepatology. 2021 Jun;73(6):2099-2109. doi: 10.1002/hep.31797.
  • Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors. Turon F, Driever EG, Baiges A, Cerda E, García-Criado Á, Gilabert R, Bru C, Berzigotti A, Nuñez I, Orts L, Reverter JC, Magaz M, Camprecios G, Olivas P, Betancourt-Sanchez F, Perez-Campuzano V, Blasi A, Seijo S, Reverter E, Bosch J, Borràs R, Hernandez-Gea V, Lisman T, Garcia-Pagan JC. J Hepatol. 2021 Jul 29:S0168-8278(21)01946-2. doi: 10.1016/j.jhep.2021.07.020.
  • Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis. Waldthaler A, Schramm C, Bergquist A. Eur J Med Genet. 2021 Jun;64(6):104231. doi: 10.1016/j.ejmg.2021.104231.
  • Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey. Zecher BF, Buescher G, Willemse J, Walmsley M, Taylor A, Leburgue A, Schramm C, Lohse AW, Sebode M. United European Gastroenterol J. 2021 Sep;9(7):797-808. doi: 10.1002/ueg2.12100
  • Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With Cirrhosis. Caporali C, Turco L, Prampolini F, Quaretti P, Bianchini M, Saltini D, Miceli F, Casari F, Felaco D, Garcia-Pagan JC, Trebicka J, Senzolo M, Guerrini GP, Di Benedetto F, Torricelli P, Villa E, Schepis F. Hepatology. 2021 Jul 4. doi: 10.1002/hep.32037.
  • Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison. Montali L, Gragnano A, Miglioretti M, Frigerio A, Vecchio L, Gerussi A, Cristoferi L, Ronca V, D'Amato D, O'Donnell SE, Mancuso C, Lucà M, Yagi M, Reig A, Jopson L, Pilar S, Jones D, Pares A, Mells G, Tanaka A, Carbone M, Invernizzi P. J Transl Autoimmun. 2021 Jan 6;4:100081. doi: 10.1016/j.jtauto.2021.100081.
  • Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas. Wege H, Schulze K, von Felden J, Calderaro J, Reig M; rare liver tumors working group of the European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Eur J Med Genet. 2021 Aug 18:104313. doi: 10.1016/j.ejmg.2021.104313.
  • Reply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered". Mallet V; Keta-Cov research group. J Hepatol. 2021 Jun 24:S0168-8278(21)00444-X. doi: 10.1016/j.jhep.2021.06.024.
  • Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response. Mandorfer M, Turon F, Lens S, Baiges A, García-Criado Á, Darnell A, Belmonte E, Ferrusquía-Acosta J, Magaz M, Perez-Campuzano V, Olivas P, Bauer D, Casanovas G, Torres F, Mariño Z, Forns X, Hernández-Gea V, García-Pagán JC. Liver Int. 2021 Jul 9. doi: 10.1111/liv.15009.
  • Salvage TIPS in cirrhotic patients with variceal bleeding: MELD, lactates and « à la carte » decision. Allaire M, Garcia-Pagán JC, Walter A, Bureau C, Thabut D. Hepatology. 2021 Aug 5. doi: 10.1002/hep.32091.
  • Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool. Murillo Perez CF, Gulamhusein A, Carbone M, Trivedi PJ, van der Meer AJ, Corpechot C, Battezzati PM, Lammers WJ, Cazzagon N, Floreani A, Parés A, Nevens F, Lleo A, Mayo MJ, Kowdley KV, Ponsioen CY, Dalekos GN, Gatselis NK, Thorburn D, Mason AL, Janssen H, Verhelst X, Bruns T, Lindor KD, Chazouillères O, Invernizzi P, Hansen BE, Hirschfield GM; GLOBAL PBC Study Group. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e266-e273. doi: 10.1097/MEG.0000000000002029.
  • The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease. Lisman T, Hernandez-Gea V, Magnusson M, Roberts L, Stanworth S, Thachil J, Tripodi A. J Thromb Haemost. 2021 Apr;19(4):1116-1122. doi: 10.1111/jth.15239.
  • The genetic architecture of primary biliary cholangitis. Gerussi A, Carbone M, Corpechot C, Schramm C, Asselta R, Invernizzi P. Eur J Med Genet. 2021 Sep;64(9):104292. doi: 10.1016/j.ejmg.2021.104292.
  • Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Hepatology. 2021 Jan;73(1):366-413. doi: 10.1002/hep.31646.

2020

  • 2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis. Thiele M, Hugger MB, Kim Y, Rautou PE, Elkrief L, Jansen C, Verlinden W, Allegretti G, Israelsen M, Stefanescu H, Piscaglia F, García-Pagán JC, Franque S, Berzigotti A, Castera L, Jeong WK, Trebicka J, Krag A. Liver Int. 2020 Jun;40(6):1435-1446. doi: 10.1111/liv.14439. Epub 2020 Apr 8.
  • Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis. Ferrusquía-Acosta J, Bassegoda O, Turco L, Reverter E, Pellone M, Bianchini M, Pérez-Campuzano V, Ripoll E, García-Criado Á, Graupera I, García-Pagán JC, Schepis F, Senzolo M, Hernández-Gea V. J Hepatol. 2020 Oct 14:S0168-8278(20)33683-7. doi: 10.1016/j.jhep.2020.10.003.
  • Budd-Chiari syndrome. Coilly A, Potier P, Broué P, Kounis I, Valla D, Hillaire S, Lambert V, Dutheil D, Hernández-Gea V, Plessier A, Vilgrain V, Bureau C. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):420-425. doi: 10.1016/j.clinre.2020.03.015.
  • Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z.
  • Congenital portosystemic shunts: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Guérin F, Franchi Abella S, McLin V, Ackermann O, Girard M, Cervoni JP, Savale L, Hernandez-Gea V, Valla D, Hillaire S, Dutheil D, Bureau C, Gonzales E, Plessier A. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):452-459. doi: 10.1016/j.clinre.2020.03.004.
  • Drug induced liver injury and vascular liver disease. Larrey D, Meunier L, Valla D, Hillaire S, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):471-479. doi: 10.1016/j.clinre.2020.03.020.
  • Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis. Hedin CRH, Sado G, Ndegwa N, Lytvyak E, Mason A, Montano-Loza A, Gerussi A, Saffioti F, Thorburn D, Nilsson E, Larsson G, Moum BA, van Munster KN, Ponsioen CY, Levy C, Nogueira NF, Bowlus CL, Gotlieb N, Shibolet O, Lynch KD, Chapman RW, Rupp C, Vesterhus M, Jørgensen KK, Rorsman F, Schramm C, Sabino J, Vermeire S, Zago A, Cazzagon N, Marschall HU, Ytting H, Ben Belkacem K, Chazouilleres O, Almer S; International PSC Study Group, Bergquist A. Clin Gastroenterol Hepatol. 2020 Feb 15:S1542-3565(20)30182-8. doi: 10.1016/j.cgh.2020.02.014.
  • Extrahepatic portal vein obstruction (EHPVO) in cirrhosis. Abergel A, Gasperment M, Nery FG, Buchard B, Lebreton A, Hordonneau C, Duron C, Valla D, Sophie H, Ledain-Rautou E, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Francoz C. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):497-502. doi: 10.1016/j.clinre.2020.03.014.
  • Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆. Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, Burt AD, Bedossa P, Palmer J, Liu YL, Aithal GP, Allison M, Yki-Järvinen H, Vacca M, Dufour JF, Invernizzi P, Prati D, Ekstedt M, Kechagias S, Francque S, Petta S, Bugianesi E, Clement K, Ratziu V, Schattenberg JM, Valenti L, Day CP, Cordell HJ, Daly AK; EPoS Consortium Investigators. J Hepatol. 2020 Sep;73(3):505-515. doi: 10.1016/j.jhep.2020.04.003.Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z.
  • Genotype correlates with the natural history of severe bile salt export pump deficiency. van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Algoufi T, Mazhar N, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler BR, Hulscher JBF, Serranti D, Arikan C, Polat E, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Calvo PL, Grabhorn E, Sturm E, van der Woerd WJ, Kamath BM, Wang JS, Li L, Durmaz Ö, Onal Z, Bunt TM, Hansen B, Verkade HJ. J Hepatol. 2020 Feb 19. pii: S0168-8278(20)30105-7. doi: 10.1016/j.jhep.2020.02.007.
  • High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation. Pape S, Gevers TJG, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Taubert R, Jaeckel E, Manns MP, Papp M, Sipeki N, Stickel F, Efe C, Ozaslan E, Purnak T, Nevens F, Kessener DJN, Kahraman A, Wedemeyer H, Hartl J, Schramm C, Lohse AW, Heneghan MA, Drenth JPH. Liver Int. 2020 May 14. doi: 10.1111/liv.14513.
  • Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis. Ronca V, Mancuso C, Milani C, Carbone M, Oo YH, Invernizzi P. J Leukoc Biol. 2020 Aug;108(2):659-671. doi: 10.1002/JLB.5MR0320-200R.
  • Ischemic cholangiopathy: An update. Goria O, Archambeaud I, Lemaitre C, Dutheil D, Plessier A, Rautou PE, Hernandez-Gea V, Valla D. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):486-490. doi: 10.1016/j.clinre.2020.03.018.
  • Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi*Z Variant of alpha-1 antitrypsin (Pi*MZ vs Pi*ZZ genotype) and Non-carriers. Schneider CV*, Hamesch K*, Gross A, Mandorfer M, Moeller LS, Pereira V, Pons M, Kuca P, Reichert MC, Benini F, Burbaum B, Voss J, Gutberlet M, Woditsch V, Lindhauer C, Fromme M, Kümpers J, Bewersdorf L, Schäfer B, Eslam M, Bals R, Janciauskiene S, Carvão J, Neureiter D, Zhou B, Wöran K, Bantel H, Geier A, Dirrichs T, Stickel F, Teumer A, Verbeek J, Nevens F, Govaere O, Krawczyk M, Roskams T, Haybaeck J, Lurje G, Chorostowska-Wynimko J, Genesca J, Reiberger T, Zoller H, Lammert F, Krag A, George J, Anstee QM, Trauner M, Datz C, Gaisa NT, Denk H, Trautwein C, Aigner E, Strnad P 2020 May 3. Pii: S0016-5085(20)30577-1 * equal contribution. Gastroenterology (2020), doi: https://doi.org/10.1053/j.gastro.2020.04.058.
  • Liver stiffness by transient elastography to detect porto-sinusoidal vascular liver disease with portal hypertension. Elkrief L, Lazareth M, Chevret S, Paradis V, Magaz M, Blaise L, Rubbia-Brandt L, Moga L, Durand F, Payancé A, Plessier A, Chaffaut C, Valla D, Malphettes M, Diaz A, Nault JC, Nahon P, Audureau E, Ratziu V, Castera L, Garcia Pagan JC, Ganne-Carrie N, Rautou PE; ANRS CO12 CirVir group. Hepatology. 2020 Dec 21. doi: 10.1002/hep.31688.
  • Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis. Corpechot C, Chazouillères O, Belnou P, Montano-Loza AJ, Mason A, Ebadi M, Eurich D, Chopra S, Jacob D, Schramm C, Sterneck M, Bruns T, Reuken P, Rauchfuss F, Roccarina D, Thorburn D, Gerussi A, Trivedi P, Hirschfield G, McDowell P, Nevens F, Boillot O, Bosch A, Giostra E, Conti F, Poupon R, Parés A, Reig A, Donato MF, Malinverno F, Floreani A, Russo FP, Cazzagon N, Verhelst X, Goet J, Harms M, van Buuren H, Hansen B, Carrat F, Dumortier J; Global PBC Study Group. J Hepatol. 2020 Sep;73(3):559-565. doi: 10.1016/j.jhep.2020.03.043.
  • Management of anticoagulation in adult patients with chronic parenchymal or vascular liver disease: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Ollivier-Hourmand I, Nguyen N, De Gottardi A, Valla D, Hillaire S, Dutheil D, Bureau C, Hernandez-Gea V, De Raucourt E, Plessier A. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):438-446. doi: 10.1016/j.clinre.2020.03.006.
  • Management of patients with autoimmune liver disease during COVID-19 pandemic. Lleo A, Invernizzi P, Lohse AW, Aghemo A, Carbone M. J Hepatol. 2020 Aug;73(2):453-455. doi: 10.1016/j.jhep.2020.04.002. Epub 2020 Apr 10.
  • Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. Gerussi A, Bernasconi DP, O'Donnell SE, Lammers WJ, Van Buuren H, Hirschfield G, Janssen H, Corpechot C, Reig A, Pares A, Battezzati PM, Zuin MG, Cazzagon N, Floreani A, Nevens F, Gatselis N, Dalekos G, Mayo MJ, Thorburn D, Bruns T, Mason AL, Verhelst X, Kowdley K, van der Meer A, Niro GA, Beretta-Piccoli BT, Marzioni M, Belli LS, Marra F, Valsecchi MG, Lindor KD, Invernizzi P, Hansen BE, Carbone M. Clin Gastroenterol Hepatol. 2020 Aug 7;S1542-3565(20)31083-1. doi: 10.1016/j.cgh.2020.08.006.
  • Open challenges in the management of autoimmune hepatitis. Gerussi A, Halliday N, Carbone M, Invernizzi P, Thorburn D. Minerva Gastroenterol Dietol. 2020 Dec 3. doi: 10.23736/S1121-421X.20.02805-6.
  • Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction. Elkrief L, Houssel-Debry P, Ackermann O, Franchi-Abella S, Branchereau S, Valla D, Hillaire S, Dutheil D, Plessier A, Hernandez-Gea V, Bureau C. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):491-496. doi: 10.1016/j.clinre.2020.03.016.
  • Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Giudicelli H, Rautou PE, Paradis V, Bedossa P, Goria O, Lambert V, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Valla D. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):447-451. doi: 10.1016/j.clinre.2020.03.005.
  • Pregnancy and vascular liver diseases. Payancé A, Ceccaldi PF, De Raucourt E, Valla D, Hillaire S, Dutheil D, Hernandez-Gea V, Bureau C, Plessier A. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):433-437. doi: 10.1016/j.clinre.2020.03.007.
  • Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months. Pape S, Gevers TJG, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Taubert R, Jaeckel E, Manns MP, Papp M, Sipeki N, Stickel F, Efe C, Ozaslan E, Purnak T, Nevens F, Kessener DJN, Kahraman A, Wedemeyer H, Hartl J, Schramm C, Lohse AW, Drenth JPH, Heneghan MA. Clin Gastroenterol Hepatol. 2020 Jun;18(7):1609-1617.e4. doi: 10.1016/j.cgh.2019.11.013. Epub 2019 Nov 9.
  • Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. Trebicka J, Gu W, Ibáñez-Samaniego L, Hernández-Gea V, Pitarch C, Garcia E, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Silva-Junior G, Martinez J, Genescà J, Bureau C, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud L, Ferreira CN, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Weiss E, Catalina MV, Erasmus HP, Uschner FE, Schulz M, Brol MJ, Praktiknjo M, Chang J, Krag A, Nevens F, Calleja JL, Robic MA, Conejo I, Albillos A, Rudler M, Alvarado E, Guardascione MA, Tantau M, Bosch J, Torres F, Pavesi M, Garcia-Pagán JC, Jansen C, Bañares R; International Variceal Bleeding Observational Study Group and Baveno Cooperation. J Hepatol. 2020 Nov;73(5):1082-1091. doi: 10.1016/j.jhep.2020.04.024.
  • Recent (non-cirrhotic) extrahepatic portal vein obstruction. Heurgué A, Habes D, Brugel M, Franchi-Abella S, Condat B, Valla D, Hillaire S, Debray D, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Payancé A. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):460-465. doi: 10.1016/j.clinre.2020.03.003.
  • Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Soret J, Debray D, Fontbrune FS, Kiladjian JJ, Saadoun D, Latour RP, Valla D, Hernandez-Gea V, Hillaire S, Dutheil D, Plessier A, Bureau C, De Raucourt E. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):410-419. doi: 10.1016/j.clinre.2020.03.010.
  • Second-line and Third-line therapy for Autoimmune Hepatitis A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. Lohse AW, Sebode M, Jørgensen MH, Ytting H, Karlsen TH, Kelly D, Manns MP, Vesterhus M; European Reference Network on Hepatological Diseases (ERN RARE-LIVER) and of the International Autoimmune Hepatitis Group (IAIHG). J Hepatol. 2020 Jul 21:S0168-8278(20)30470-0. doi: 10.1016/j.jhep.2020.07.023. Online ahead of print.
  • Sinusoidal obstruction syndrome. de Lédinghen V, Villate A, Robin M, Decraecker M, Valla D, Hillaire S, Hernandez-Gea V, Dutheil D, Bureau C, Plessier A. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):480-485. doi: 10.1016/j.clinre.2020.03.019
  • Social and medical support initiatives in vascular liver diseases in France, from child to adult. Plessier A, Gasperment M, Debray D, Brault C, Ollivier-Hourmand I, Dutheil D, Leclercq A, Devictor J, Hernández-Gea V, Le Beux E, Goria O. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):466-470. doi: 10.1016/j.clinre.2020.03.002.

2019

  • Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study. Elkrief L, Ferrusquia-Acosta J, Payancé A, Moga L, Tellez L, Praktiknjo M, Procopet B, Farcau O, De Lédinghen V, Yuldashev R, Tabchouri N, Barbier L, Dumortier J, Menahem B, Magaz M, Hernández-Gea V, Albillos A, Trebicka J, Spahr L, De Gottardi A, Plessier A, Valla D, Rubbia-Brandt L, Toso C, Bureau C, Garcia-Pagan JC, Rautou PE; for VALDIG, an EASL consortium. Hepatology. 2019 Sep;70(3):911-924. doi: 10.1002/hep.30628.
  • Clinical management of autoimmune hepatitis. Pape S, Schramm C, Gevers TJ. United European Gastroenterol J. 2019 Nov;7(9):1156-1163. doi: 10.1177/2050640619872408. Epub 2019 Aug 25. Review.
  • Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis. Hernández-Gea V, De Gottardi A, Leebeek FWG, Rautou PE, Salem R, Garcia-Pagan JC. J Hepatol. 2019 Jul;71(1):175-199. doi: 10.1016/j.jhep.2019.02.015. Epub 2019 Feb 26. Review.
  • Depression in patients with autoimmune hepatitis: the need for detailed psychiatric assessment. Janik MK, Wunsch E, Moskwa M, Raszeja-Wyszomirska J, Krawczyk M, Milkiewicz P. Pol Arch Intern Med. 2019 Sep 30;129(9):645-647. doi: 10.20452/pamw.14898. Epub 2019 Jul 12.
  • Efficacy of rituximab in difficult-to-manage Autoimmune Hepatitis: Results from the International Autoimmune Hepatitis Group. Than NN, Hodson J, Schmidt-Martin D, Taubert R, Wawman RE, Botter M, Gautam N, Bock K, Jones R, Appanna GD, Godkin A, Montano-Loza AJ, Lammert F, Schramm C, Manns MP, Swain M, Burak KW, Adams DH, Hirschfield GM, Oo YH. JHEP Reports. Nov 2019. Volume 1, Issue 6, Pages 437-445. Doi: 10.1016/j.jhepr.2019.10.005.
  • Liver Fibrosis and Metabolic Alterations in Adults with Alpha-1 Antitrypsin Deficiency Caused by the Pi*ZZ Mutation; Hamesch K, Mandorfer M, Pereira VM, Moeller LS, Pons M, Dolman GE, Reichert MC, Heimes CV, Woditsch V, Voss J, Lindhauer C, Fromme M, Spivak I, Guldiken N, Zhou B, Arslanow A, Schaefer B, Zoller H, Aigner E, Reiberger T, Wetzel M, Siegmund B, Simões C, Gaspar R, Maia L, Costa D, Bento-Miranda M, van Helden J, Yagmur E, Bzdok D, Stolk J, Gleiber W, Knipel V, Windisch W, Mahadeva R, Bals R, Koczulla R, Barrecheguren M, Miravitlles M, Janciauskiene S, Stickel F, Lammert F, Liberal R, Genesca J, Griffiths WJ, Trauner M, Krag A, Trautwein C, Strnad P. Gastroenterology 2019 Sep;157(3):705-719.e18
  • Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER. Bernts LHP, Jones DEJ, Kaatee MM, Lohse AW, Schramm C, Sturm E, Drenth JPH. ORPHANET JOURNAL OF RARE DISEASES. JUL 8, 2019. Doi: 10.1186/s13023-019-1152-z.
  • The challenges of primary biliary cholangitis: What is new and what needs to be done. Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME. J Autoimmun. 2019 Dec;105:102328. doi: 10.1016/j.jaut.2019.102328. Epub 2019 Sep 20. Review.

2018

  • Drug holiday in patients with polycystic liver disease treated with somatostatin analogues. van Aerts RMM, Kolkman M, Kievit W, Gevers TJG, Nevens F, Drenth JPH. Therap Adv Gastroenterol. 2018 Oct 3;11:1756284818804784. doi: 10.1177/1756284818804784.
  • Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. Strnad P, Buch S, Hamesch K, Fischer J, Rosendahl J, Schmelz R, Brueckner S, Brosch M, Heimes CV, Woditsch V, Scholten D, Nischalke HD, Janciauskiene S, Mandorfer M, Trauner M, Way MJ, McQuillin A, Reichert MC, Krawczyk M, Casper M, Lammert F, Braun F, von Schönfels W, Hinz S, Burmeister G, Hellerbrand C, Teufel A, Feldman A, Schattenberg JM, Bantel H, Pathil A, Demir M, Kluwe J, Boettler T, Ridinger M, Wodarz N, Soyka M, Rietschel M, Kiefer F, Weber T, Marhenke S, Vogel A, Hinrichsen H, Canbay A, Schlattjan M, Sosnowsky K, Sarrazin C, von Felden J, Geier A, Deltenre P, Sipos B, Schafmayer C, Nothnagel M, Aigner E, Datz C, Stickel F, Morgan MY, Hampe J, Berg T, Trautwein C. Gut. 2018 Aug 1. pii: gutjnl-2018-316228. doi: 10.1136/gutjnl-2018-316228.